carbon tetrachloride has been researched along with didymin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, F; Huang, Q; Lin, X; Lu, C; Lu, S; Nie, J; Zhu, X; Zhuo, L | 1 |
| Fang, B; Huang, Q; Li, C; Li, Y; Lin, X; Xiong, Y | 1 |
2 other study(ies) available for carbon tetrachloride and didymin
| Article | Year |
|---|---|
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytokines; Flavonoids; Glycosides; Humans; Inflammation Mediators; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Origanum; Oxazolidinones; Phosphatidylethanolamine Binding Protein; RAW 264.7 Cells; Reactive Oxygen Species | 2017 |
Didymin Ameliorates Liver Fibrosis by Alleviating Endoplasmic Reticulum Stress and Glycerophospholipid Metabolism: Based on Transcriptomics and Metabolomics.
Topics: Animals; Apoptosis; Carbon Tetrachloride; Endoplasmic Reticulum Stress; Flavonoids; Glycerophospholipids; Glycosides; Inflammation; Liver; Liver Cirrhosis; Metabolomics; Mice; Transcriptome | 2022 |